Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85M Buy
154,790
+11,768
+8% +$252K ﹤0.01% 1102
2026
Q1
$2.89M Buy
143,022
+25,541
+22% +$568K ﹤0.01% 1048
2025
Q4
$2.25M Buy
117,481
+10,340
+10% +$218K ﹤0.01% 1142
2025
Q3
$2.76M Buy
107,141
+93,319
+675% +$2.18M ﹤0.01% 1020
2025
Q2
$307K Buy
+13,822
New +$204K ﹤0.01% 1500

Other funds holding ADNT

Amundi's ADNT Position: Q2 2026 in Review

Amundi increased its Adient (ADNT) stake by 8.2% in Q2 2026, buying an estimated $252K and bringing the position to 154,790 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1102.

Amundi first reported a position in ADNT in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.89M in Q1 2026. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Amundi held 154,790 shares of Adient worth $2.85M as of Q2 2026.
  • Amundi bought 11,768 Adient shares in Q2 2026, an estimated $252K.
  • Adient made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1102 holding.
  • Amundi first reported a position in Adient in Q2 2025 and has held it in 5 quarters since.
  • Amundi's Adient position peaked at $2.89M in Q1 2026.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.